BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 4899869)

  • 41. ["L" phase bacteria: biological properties and etiopathogenetic and therapeutic prospects in infectious pathology].
    Serra P
    Policlinico Med; 1968; 75(3):165-88. PubMed ID: 5738531
    [No Abstract]   [Full Text] [Related]  

  • 42. Phenotypic expression of an envC-division mutant of Escherichia coli K12.
    Starka J; Di Savino D; Michel G; Rodolakis A; Thomas P
    Ann Microbiol (Paris); 1974 Sep; 125 B(2):227-32. PubMed ID: 4218460
    [No Abstract]   [Full Text] [Related]  

  • 43. [Production and biological properties of L-like mutants (11r) of Escherichia coli].
    Androsov VV; Levashev VS
    Mikrobiologiia; 1975; 44(3):435-41. PubMed ID: 1099408
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Microbiological chemistry.
    Haslam E
    Chem Br; 1968 Jan; 4(1):16-7. PubMed ID: 5640875
    [No Abstract]   [Full Text] [Related]  

  • 45. [Delimitation of the concept of L forms of bacteria: protoplasts, spheroplasts and L forms].
    TULASNE R; MINCK R; KIRN A; KREMBEL J
    Ann Inst Pasteur (Paris); 1960 Dec; 99():859-74. PubMed ID: 13778578
    [No Abstract]   [Full Text] [Related]  

  • 46. Induction and identification of L-forms of bacteria.
    Madoff S; Burke ME; Dienes L
    Ann N Y Acad Sci; 1967 Jul; 143(1):755-9. PubMed ID: 4964014
    [No Abstract]   [Full Text] [Related]  

  • 47. [Studies on bacterial L-forms in ocular infections. I. Isolation and sensitivity of antibiotics (author's transl)].
    Oishi M; Imai M; Takahashi T; Nakatsue T; Takizawa H
    Nippon Ganka Gakkai Zasshi; 1973 Sep; 77(9):1175-83. PubMed ID: 4797093
    [No Abstract]   [Full Text] [Related]  

  • 48. Preparation of spheroplasts from Streptococcus lactis.
    Kruse H; Hurst A
    Can J Microbiol; 1972 Jun; 18(6):825-31. PubMed ID: 4624548
    [No Abstract]   [Full Text] [Related]  

  • 49. Cell envelopes of gram negative bacteria: composition, response to chelating agents and susceptibility of whole cells to antibacterial agents.
    Haque H; Russell AD
    J Appl Bacteriol; 1976 Feb; 40(1):89-99. PubMed ID: 818069
    [No Abstract]   [Full Text] [Related]  

  • 50. [Comparative studies of Mycoplasma (PPLO), bacterial protoplasts and L-forms].
    RAZIN S; ARGAMAN M
    Harefuah; 1962 Apr; 62():259-63. PubMed ID: 14490760
    [No Abstract]   [Full Text] [Related]  

  • 51. Protoplasts and spheroplasts of gram-negative bacteria (with special emphasis on Proteus mirabilis).
    Martin HH
    Experientia Suppl; 1983; 46():213-25. PubMed ID: 6425077
    [No Abstract]   [Full Text] [Related]  

  • 52. Bacterial L-forms on tap: an improved methodology to generate Bacillus subtilis L-forms heralds a new era of research.
    Devine KM
    Mol Microbiol; 2012 Jan; 83(1):10-3. PubMed ID: 22126136
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rapid formation of protoplasts of Streptomyces griseoflavus and their fine structure.
    Sagara Y; Fukui K; Ota F; Yoshida N; Kashiyama T
    Jpn J Microbiol; 1971 Jan; 15(1):73-84. PubMed ID: 5313615
    [No Abstract]   [Full Text] [Related]  

  • 54. Lysis of Mycoplasma, bacterial protoplasts, spheroplasts and L-forms by various agents.
    RAZIN S; ARGAMAN M
    J Gen Microbiol; 1963 Jan; 30():155-72. PubMed ID: 13973364
    [No Abstract]   [Full Text] [Related]  

  • 55. [On enzymatic lysis of pathological bacterial forms (spheroplasts, protoplasts, L forms)].
    TERRANOVA T
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1960; 53():297-308. PubMed ID: 13776022
    [No Abstract]   [Full Text] [Related]  

  • 56. Are wall-defective microbial variants important in clinical infectious diseases?
    Watanakunakorn C
    J Antimicrob Chemother; 1979 May; 5(3):239-41. PubMed ID: 383679
    [No Abstract]   [Full Text] [Related]  

  • 57. [Structural features of bacteria after losing their cell walls].
    Kats LN; Konstantinova ND; ProzorovskiÄ­ SV
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Jul; (7):8-15. PubMed ID: 7025533
    [No Abstract]   [Full Text] [Related]  

  • 58. Reversion to the streptococcal state of enterococcal protoplasts, spheroplasts, and L-forms.
    King JR; Gooder H
    J Bacteriol; 1970 Sep; 103(3):692-6. PubMed ID: 4919988
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Protoplast fragmentation as one of the possible mechanisms of L-transformation of bacteria (Clostridium perfringens)].
    VysotskiÄ­ VV; Gorshkova VI
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Feb; (2):86-90. PubMed ID: 208329
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of aerobic and anaerobic growth on the cell wall of Staphylococcus aureus.
    O'Brien TC; Kennedy ER
    Antonie Van Leeuwenhoek; 1971; 37(2):153-60. PubMed ID: 4996956
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.